Design and validation of a low-cost photomodulator for in vivo photoactivation of a mGluR5 inhibitor
Authors (first, second and last of 6)

Biomedical Engineering Letters Now Indexed in SCIE
We are pleased to announce that Biomedical Engineering Letters has been newly included in Science Citation Index Expanded (SCIE) of Web of Science. Consequently, articles published from Volume 9 (2019) onward will be indexed in the Web of Science Core Collection. Further, the journal expects to receive its first Journal Impact Factor (JIF) in the June 2022 release of Journal Citation Reports (JCR). Previously, the journal was added to SCOPUS, PubMedCentral, Emerging Sources Citation Index (ESCI) and many other abstract and citation databases.
Biomedical Engineering Letters (BMEL) is an interdisciplinary, international journal devoted to the publication of original investigations concerned with major aspects of biomedical engineering and applied biophysics. BMEL aims to present the innovative experimental science and technological development in the biomedical field as well as clinical application of new development. The article must contain original biomedical engineering content, defined as development, theoretical analysis, and evaluation/validation of a new technique. BMEL publishes the following types of papers: original articles, review articles, editorials, and letters to the editor. All the papers are reviewed in single-blind fashion.
Single-blind peer review
The journal follows a single-blind review procedure, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous. Single-blind peer review is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
Volume 13
Robot Surgery in Orthopedic Field -Where We Are-
We are pleased to announce that Biomedical Engineering Letters has been newly included in Science Citation Index Expanded (SCIE) of Web of Science. Consequently, articles published from Volume 9 (2019) onward will be indexed in the Web of Science Core Collection. Further, the journal expects to receive its first Journal Impact Factor (JIF) in the June 2022 release of Journal Citation Reports (JCR). Previously, the journal was added to SCOPUS, PubMedCentral, Emerging Sources Citation Index (ESCI) and many other abstract and citation databases.
The SCIE indexing is a significant milestone for the journal, and would not have been possible without the concerted efforts of many people. We would like to thank all the authors, reviewers, and guest editors for their outstanding support and contribution.
Biomedical Engineering Letters (BMEL) is an official journal of the Korean Society of Medical and Biological Engineering (KOSOMBE). The KOSOMBE is a scientific and professional organization founded in 1979, and a member of International Federation for Medical and Biological Engineering (IFMBE).
Original Articles should contain no more than 6,000 words. This word limit includes all data: title page, abstract, text, disclosure, acknowledgments, key points, references, figure legends, and tables.
A maximum of 8 figures (maximum of 16 parts in total with no more than 4 parts per figure preferred), 8 tables, and 60 references is allowed. A one−paragraph abstract of 150 to 250 words must accompany Original and Review Articles. In the Original Articles, it should state concisely the reason for the study, what was done, what was found, what was concluded, and the relevance.
Avoid the most common mistakes and prepare your manuscript for journal editors.
Learn more